Dr. Ring, former Chief Executive Officer of Kaerus Bioscience, former Chief Scientific Officer of Autism Speaks, and former Head of Autism Research at Pfizer, joins Pano Therapeutics’ Scientific Advisory Board as Lead Neurodevelopmental Disorder Advisor to support scientific strategy, business development, and partnering as the company advances PAN1195 toward clinical development in Fragile X Syndrome.

Read More